Ginkgo Bioworks Holdings, Inc. (DNA) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-5.64 | +46.5% |
| 2024 | $-10.54 | +42.6% |
| 2023 | $-18.37 | +63.4% |
| 2022 | $-50.20 | -3511.5% |
| 2021 | $-1.39 | -1290.0% |
| 2020 | $-0.10 | +0.0% |
| 2019 | $-0.10 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-5.64 | +46.5% |
| 2024 | $-10.54 | +42.6% |
| 2023 | $-18.37 | +63.4% |
| 2022 | $-50.20 | -3511.5% |
| 2021 | $-1.39 | -1290.0% |
| 2020 | $-0.10 | +0.0% |
| 2019 | $-0.10 | — |